PAVmed Inc.
PAVM
$0.72
-$0.04-5.26%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 22.15% | 166.27% | 378.63% | 375.71% | 550.40% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.15% | 166.27% | 378.63% | 375.71% | 550.40% |
| Cost of Revenue | -24.64% | -0.40% | 8.37% | 48.56% | 77.72% |
| Gross Profit | 53.54% | 51.80% | 45.74% | 3.87% | -22.65% |
| SG&A Expenses | -25.51% | -17.44% | -21.29% | -28.18% | -19.81% |
| Depreciation & Amortization | -72.33% | -47.35% | -26.42% | -12.88% | 13.23% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -33.36% | -23.96% | -25.91% | -29.24% | -22.10% |
| Operating Income | 35.34% | 27.70% | 29.72% | 32.03% | 24.47% |
| Income Before Tax | 135.86% | 111.43% | 23.28% | 28.59% | 23.22% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 135.86% | 111.43% | 23.28% | 28.59% | 23.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -24.69% | -8.73% | -4.62% | -10.59% | 5.85% |
| Net Income | 162.00% | 134.45% | 26.95% | 31.75% | 27.88% |
| EBIT | 35.34% | 27.70% | 29.72% | 32.03% | 24.47% |
| EBITDA | 34.28% | 27.34% | 30.10% | 32.90% | 25.69% |
| EPS Basic | 129.64% | 105.99% | 34.96% | 38.97% | 38.56% |
| Normalized Basic EPS | 67.60% | 45.65% | 49.04% | 50.42% | 41.50% |
| EPS Diluted | 74.21% | 58.80% | 34.95% | 38.96% | 38.55% |
| Normalized Diluted EPS | 74.02% | 50.37% | 49.04% | 50.42% | 41.50% |
| Average Basic Shares Outstanding | 33.77% | 32.38% | 30.09% | 27.28% | 21.77% |
| Average Diluted Shares Outstanding | 571.90% | 159.57% | 30.09% | 27.28% | 21.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |